Our Mission
Advancing Cancer Diagnostics, Improving Lives
Our Vision
From translational research to patient treatment, we envision a world where comprehensive insights enrich cancer diagnosis and offer reassurance to all patients.
News & Events
Leica Biosystems Strengthens Portfolio with FDA Clearance of Class II Mismatch Repair (MMR) Panel
The BOND MMR Antibody Panel is now available for clinical use on BOND-III and BOND-MAX Immunohistochemistry (IHC) automated instruments.
Paige and Leica Biosystems Announce Expanded Partnership to Enhance Use of Image Management and Artificial Intelligence Technology in Global Digital Pathology Workflows
Leica Biosystems to adopt Paige's image management and AI system for sale with Leica Biosystems Aperio digital pathology slide scanners
Celebrating Leica Biosystems 150th Anniversary
The history of Leica Biosystems is a history of science and technology innovation.
Leica Biosystems at a Glance
150+ Years of Innovation
|
2012 - Present |
New Era of Science & Technology |
|
2005 - 2011 |
Global Expansion Accelerates |
|
1989 - 2004 |
Structuring for Comprehensive Workflow |
|
1930 - 1988 |
Novel Products Drive Company Growth |
|
1900 - 1930 |
Microtomy Technology Advances Amidst Wartime Realities |
|
1872 - 1899 |
The Creation of the Microtome and the Early Years of R. Jung GMBH |